ClinicalTrials.Veeva

Menu

At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

P

ProofPilot

Status

Unknown

Conditions

COVID-19
COVID19
Coronavirus

Treatments

Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Study type

Interventional

Funder types

Industry
Other

Identifiers

Details and patient eligibility

About

Radish Health and ProofPilot in coordination with Sanesco are running this study to help establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among individuals who have tested positive, or suspect they have previous contracted from COVID-19 and recovered. The study also aims to examine how the results of those tests change social-distancing behaviors and general anxiety over 8 weeks post-test.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Reside and Currently in New York City
  • Does not have a blood clotting disease
  • Is not abnormally queasy about taking a blood sample
  • Not on any blood thinning medications
  • Able to consent
  • Willingness to take a blood sample
  • Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered

Trial design

Primary purpose

Device Feasibility

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

600 participants in 4 patient groups

Past Positive COVID-19 confirmed
Other group
Description:
Invited participants who Radish Health has completed a positive COVID-19 test who have recovered from all symptoms for more than 14 days.
Treatment:
Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Physician Diagnosed: Not Tested
Other group
Description:
Individuals who self report that a medical professional has told them they likely have COVID-19 (and have since recovered), but did not get a confirmatory test.
Treatment:
Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Self-Diagnosed Not Tested
Other group
Description:
Participant suspects they contracted (and have since recovered) from COVID-19, but they do not have a medical diagnosis or confirmatory test.
Treatment:
Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Likely Exposed, No Symptoms. Not Tested
Other group
Description:
Participant suspects that they've been exposed to COVID-19, but have not shown symptoms and wonder if they have antibodies so they may return to some normalcy.
Treatment:
Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

Trial contacts and locations

1

Loading...

Central trial contact

Viral Patel, MD; Matthew Amsden

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems